Phosphate Levels and Blood Pressure in Incident Hemodialysis Patients: A Longitudinal Study

Advances in Chronic Kidney Disease

Volumn 15, Issue 3, 2008, Pages 321-331

  Huang, Cindy Xin ^a   Plantinga, Laura C ^a   Fink, Nancy E ^a   Melamed, Michal L ^a   Coresh, Josef ^a   Powe, Neil R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Hemodialysis; Phosphate

Indexed keywords

PHOSPHATE;

ADULT; AGED; ANAMNESIS; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL CALCIFICATION; DIASTOLIC BLOOD PRESSURE; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; MAJOR CLINICAL STUDY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; CALCIUM; CALCIUM PHOSPHATES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPHOSPHATEMIA; HYPERTENSION, RENAL; INCIDENCE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; PHOSPHATES; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RISK FACTORS;

EID: 45149130993     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2008.04.012     Document Type: Article

References (33)

1. Agarwal R., Nissenson A.R., Batlle D., et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115 (2003) 291-297
2. HCFA-1995. Opportunities to improve care for adult in-center hemodialysis patients. Annual Report: ESRD core indicators project (January 19, 1996)
3. Rahman M., Dixit A., Donley V., et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 33 (1999) 498-506
4. Zager P.G., Nikolic J., Brown R.H., et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54 (1998) 561-569
5. Mailloux L.U. Hypertension in chronic renal failure and ESRD: Prevalence, pathophysiology, and outcomes. Semin Nephrol 21 (2001) 146-156
6. Giachelli C.M., Jono S., Shioi A., et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis 38 (2001) S34-S37
7. Block G.A., Klassen P.S., Lazarus J.M., et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 (2004) 2208-2218
8. Schucker J.J., and Ward K.E. Hyperphosphatemia and phosphate binders. Am J Health Syst Pharm 62 (2005) 2355-2361
9. O'Neill W.C. The fallacy of the calcium-phosphorus product. Kidney Int 72 (2007) 792-796
10. Spalding E.M., Chamney P.W., and Farrington K. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int 61 (2002) 655-667
11. Lorenzo S.V., and Torres R.A. Management of hyperphosphataemia in dialysis patients: Role of phosphate binders in the elderly. Drugs Aging 21 (2004) 153-165
12. Powe N.R., Klag M.J., Sadler J.H., et al. Choices for healthy outcomes in caring for end stage renal disease. Semin Dial 9 (1996) 9-11
13. U.S. Renal Data System. U.S. Renal Data System 1999 Annual Data Report: Atlas of End-Stage Renal Disease in the United States (1999), National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD
14. Greenfield S., Sullivan L., Silliman R.A., et al. Principles and practice of case mix adjustment: Applications to end-stage renal disease. Am J Kidney Dis 24 (1994) 298-307
15. Miskulin D.C., Meyer K.B., Athienites N.V., et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 39 (2002) 324-336
16. Kinchen K.S., Sadler J., Fink N., et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137 (2002) 479-486
17. Unruh M.L., Evans I.V., Fink N.E., et al. Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. Am J Kidney Dis 46 (2005) 1107-1116
18. Delmez J.A., and Slatopolsky E. Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 19 (1992) 303-317
19. Huting J. Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis. Chest 105 (1994) 383-388
20. Raggi P., Boulay A., Chasan-Taber S., et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol 39 (2002) 695-701
21. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
22. Davies M.R., and Hruska K.A. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 60 (2001) 472-479
23. Jono S., McKee M.D., Murry C.E., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87 (2000) E10-E17
24. Moe S.M., O'Neill K.D., Duan D., et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61 (2002) 638-647
25. Shioi A., Taniwaki H., Jono S., et al. Monckeberg's medial sclerosis and inorganic phosphate in uremia. Am J Kidney Dis 38 (2001) S47-S49
26. Achinger S.G., and Ayus J.C. Left Ventricular hypertrophy: Is hyperphosphatemia among dialysis patients a risk factor?. J Am Soc Nephrol 17 (2006) S255-S261
27. Ayus J.C., Mizani M.R., Achinger S.G., et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol 16 (2005) 2778-2788
28. Klassen P.S., Lowrie E.G., Reddan D.N., et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287 (2002) 1548-1555
29. Melamed M.L., Eustace J.A., Plantinga L., et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int 70 (2006) 351-357
30. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42 (2003) S1-S201
31. Guerin A.P., London G.M., Marchais S.J., et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15 (2000) 1014-1021
32. Stubbs J.R., Liu S., Tang W., et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 18 (2007) 2116-2124
33. Leggat Jr. J.E., Orzol S.M., Hulbert-Shearon T.E., et al. Noncompliance in hemodialysis: Predictors and survival analysis. Am J Kidney Dis 32 (1998) 139-145